Human CXCR4 Antibody

Catalog # Availability Size / Price Qty
MAB171-100
MAB171-SP
Chemotaxis Induced by CXCL12/SDF‑1 alpha  and Neutralization by Human CXCR4 Antibody.
3 Images
Product Details
Citations (23)
FAQs
Supplemental Products
Reviews

Human CXCR4 Antibody Summary

Species Reactivity
Human
Specificity
Reacts specifically with human and non-human cells expressing human CXCR4 (fusin) as detected by flow cytometry. It will also react with cells expressing feline CXCR4 but not rat CXCR4. This antibody does not cross-react with other chemokine receptors.
Source
Monoclonal Mouse IgG2A Clone # 44708
Purification
Protein A or G purified from ascites
Immunogen
3T3 cells transfected with human CXCR4
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Neutralization
Measured by its ability to neutralize CXCL12/SDF‑1 alpha -induced chemotaxis in the BaF3 mouse pro‑B cell line transfected with human CXCR4. The Neutralization Dose (ND50) is typically 0.2-1.2 µg/mL in the presence of 1 ng/mL Recombinant Human/Feline/Rhesus Macaque CXCL12/SDF‑1 alpha.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Neutralization Chemotaxis Induced by CXCL12/SDF‑1 alpha  and Neutralization by Human CXCR4 Antibody. View Larger

Chemotaxis Induced by CXCL12/SDF‑1 alpha and Neutralization by Human CXCR4 Antibody. Recombinant Human/Feline/Rhesus Macaque CXCL12/SDF-1a (Catalog # 350-NS) chemoattracts the BaF3 mouse pro-B cell line transfected with human CXCR4 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Human/Feline/Rhesus Macaque CXCL12/SDF-1a (1 ng/mL) is neutralized (green line) by increasing concentrations of Human CXCR4 Monoclonal Antibody (Catalog # MAB171). The ND50 is typically 0.2-1.2 µg/mL.

Flow Cytometry Detection of Mouse CXCR4 by Flow Cytometry View Larger

Detection of Mouse CXCR4 by Flow Cytometry Anti-CXCR4 antibody reduces CXCR4 surface expression, and blocks migration toward CXCL12 and BMSCs.(A) Relative MFIR of CXCR4 surface staining after incubation of Raji transfectants with 100 µg/mL of anti-CXCR4 antibody for 30 minutes. (B) Flow cytometry histograms showing the reduction in CXCR4 expression after incubation with neutralizing anti-CXCR4 antibody. White histograms represent negative unstained controls. (C) CXCR4-blocked cells were stimulated with 100 ng/mL of CXCL12 for 5 minutes and activation of Akt and ERK1/2 proteins analyzed by western blotting. (D) CXCR4-blocked cells were subjected to migration assay for 4 hours at 37°C in 5% CO2 toward 100 ng/mL of CXCL12 (left panel) or the stromal MS-5 cell line (right panel). Cells in the lower chamber were counted by flow cytometry under a defined flow rate for 5 minutes. Number of migrated cells treated with isotypic control was considered 100%. Results are shown as the mean ± SEM of 4 independent experiments. (E) Cell viability was measured by Annexin V-PI staining in cells incubated with 100 µg/mL of anti-CXCR4 or isotypic control for 48 hours. Results are shown as the mean ± SEM of 4 independent experiments Image collected and cropped by CiteAb from the following publication (https://dx.plos.org/10.1371/journal.pone.0081221), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Mouse CXCR4 by Western Blot View Larger

Detection of Mouse CXCR4 by Western Blot Anti-CXCR4 antibody reduces CXCR4 surface expression, and blocks migration toward CXCL12 and BMSCs.(A) Relative MFIR of CXCR4 surface staining after incubation of Raji transfectants with 100 µg/mL of anti-CXCR4 antibody for 30 minutes. (B) Flow cytometry histograms showing the reduction in CXCR4 expression after incubation with neutralizing anti-CXCR4 antibody. White histograms represent negative unstained controls. (C) CXCR4-blocked cells were stimulated with 100 ng/mL of CXCL12 for 5 minutes and activation of Akt and ERK1/2 proteins analyzed by western blotting. (D) CXCR4-blocked cells were subjected to migration assay for 4 hours at 37°C in 5% CO2 toward 100 ng/mL of CXCL12 (left panel) or the stromal MS-5 cell line (right panel). Cells in the lower chamber were counted by flow cytometry under a defined flow rate for 5 minutes. Number of migrated cells treated with isotypic control was considered 100%. Results are shown as the mean ± SEM of 4 independent experiments. (E) Cell viability was measured by Annexin V-PI staining in cells incubated with 100 µg/mL of anti-CXCR4 or isotypic control for 48 hours. Results are shown as the mean ± SEM of 4 independent experiments Image collected and cropped by CiteAb from the following publication (https://dx.plos.org/10.1371/journal.pone.0081221), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CXCR4

CXCR4, also known as CD184, is a G-protein-linked seven transmembrane spanning receptor that binds stromal cell-derived factor-1 (SDF-1). CXCR4 acts as a co-factor for T-cell tropic HIV-1 and -2 viral entry into cells. While primarily a membrane protein, CXCR4 undergoes trafficking and internalization in response to stimulation with phorbol esters and ligand (1). Cytoplasmic and nuclear localization of CXCR4 has been observed in colorectal and renal carcinomas (2,3) and it has been used as the basis of prognosis and metastatic state (3,4,5).

References
  1. Orsini, M.J. et al. (1999) J. Biol. Chem. 274:31076.
  2. Zagzag, D. et al. (2005) Cancer Res. 65:6178.
  3. Speetjens, F.M. et al. (2009) Cancer Microenvironment 2:1.
  4. Wang, L. et al. (2009) Oncology Reports 22:1333.
  5. Amara, S. et al. (2015) Cancer Biomark. 15:869.
Long Name
C-X-C Motif Chemokine Receptor 4
Entrez Gene IDs
7852 (Human); 12767 (Mouse); 60628 (Rat); 483900 (Canine); 493676 (Feline)
Alternate Names
CD184; chemokine (C-X-C motif) receptor 4; chemokine (C-X-C motif), receptor 4 (fusin); C-X-C chemokine receptor type 4; CXCR4; CXC-R4; CXCR-4; D2S201E; D2S201ESDF-1 receptor; FB22; Fusin; HM89; HM89NPYRL; HSY3RR; LAP3; LAP-3; LCR1; LESTR; LESTRCD184 antigen; Leukocyte-derived seven transmembrane domain receptor; leukocyte-derived seven-transmembrane-domain receptor; lipopolysaccharide-associated protein 3; neuropeptide Y receptor Y3; NPY3R; NPY3RWHIM; NPYR; NPYRL; NPYY3R; pCXCR4; seven transmembrane helix receptor; seven-transmembrane-segment receptor, spleen; Stromal cell-derived factor 1 receptor; WHIMS

Product Datasheets

You must select a language.

x

Citations for Human CXCR4 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

23 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.
    Authors: Zhu D, Wang Z, Zhao JJ et al.
    Nat. Med.
  2. Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation.
    Authors: Wei L, Kanbe K, Lee M, Wei X, Pei M, Sun X, Terek R, Chen Q
    Dev. Biol., 2010-03-04;341(1):236-45.
  3. Engagement of the CXCL12-CXCR4 Axis in the Interaction of Endothelial Progenitor Cell and Smooth Muscle Cell to Promote Phenotype Control and Guard Vascular Homeostasis
    Authors: SF Mause, E Ritzel, A Deck, F Vogt, EA Liehn
    International Journal of Molecular Sciences, 2022-01-14;23(2):.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Neutralization
  4. Mechanisms of HIV-1 evasion to the antiviral activity of chemokine CXCL12 indicate potential links with pathogenesis
    Authors: M Armani-Tou, Z Zhou, R Gasser, I Staropoli, V Cantaloube, Y Benureau, J Garcia-Per, M Pérez-Olme, V Lorin, B Puissant-L, L Assoumou, C Delaugerre, JD Lelièvre, Y Lévy, H Mouquet, G Martin-Blo, J Alcami, F Arenzana-S, J Izopet, P Colin, B Lagane
    PloS Pathogens, 2021-04-19;17(4):e1009526.
    Species: Human
    Sample Types: Whole Cells
    Applications: Binding Assay
  5. The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3)
    Authors: F Caccuri, A Bugatti, S Corbellini, S Roversi, A Zani, P Mazzuca, S Marsico, A Caruso, C Giagulli
    Int J Mol Sci, 2019-10-24;20(21):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  6. Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment
    Authors: F Lüke, R Blazquez, RF Yamaci, X Lu, B Pregler, S Hannus, K Menhart, D Hellwig, HJ Wester, S Kropf, D Heudobler, J Grosse, J Moosbauer, M Hutterer, P Hau, MJ Riemenschn, M Bayerlová, A Bleckmann, B Polzer, T Bei beta barth, CA Klein, T Pukrop
    Oncotarget, 2018-04-10;9(27):18844-18857.
    Species: Human
    Sample Types: Whole Cells
    Applications: FCCS
  7. The MRPS18-2 protein levels correlate with prostate tumor progression and it induces CXCR4-dependent migration of cancer cells
    Authors: M Mushtaq, L Jensen, S Davidsson, OV Grygoruk, O Andrén, V Kashuba, E Kashuba
    Sci Rep, 2018-02-02;8(1):2268.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  8. [68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model - comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression
    Authors: SM Schwarzenb, J Stenzel, T Otto, HV Helldorff, C Bergner, J Kurth, S Polei, T Lindner, R Rauer, A Hohn, OW Hakenberg, HJ Wester, B Vollmar, BJ Krause
    Oncotarget, 2017-09-16;8(56):95606-95619.
    Species: Xenograft
    Sample Types: Whole Tissue
    Applications: IHC-P
  9. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
    Proc Natl Acad Sci USA, 2016-08-19;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: IHC-Fr
  10. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
    Authors: DiCosmo-Ponticello C, Hoover D, Coffman F, Cohen S, Cohen M
    Cytokine, 2014-06-06;69(1):47-55.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  11. ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation.
    Authors: Calpe E, Purroy N, Carpio C, Abrisqueta P, Carabia J, Palacio C, Castellvi J, Crespo M, Bosch F
    PLoS ONE, 2013-12-03;8(12):e81221.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  12. Verotoxin A Subunit Protects Lymphocytes and T Cell Lines against X4 HIV Infection in Vitro
    Authors: Pei Lin Shi, Beth Binnington, Darinka Sakac, Yulia Katsman, Stephanie Ramkumar, Jean Gariepy et al.
    Toxins (Basel)
  13. Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway
    Authors: Fangyuan Wei, Douglas C Moore, Lei Wei, Yanlin Li, Ge Zhang, Xiaochun Wei et al.
    Arthritis Research & Therapy
  14. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells
    Authors: Claudia Rubie, Vilma O Frick, Pirus Ghadjar, Mathias Wagner, Christoph Justinger, Sabrina K Faust et al.
    Journal of Translational Medicine
  15. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma
    Authors: Li Guo, Zhu-Mei Cui, Jia Zhang, Yu Huang
    Chinese Journal of Cancer
  16. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment
    Authors: David Simons, Gerrit Grieb, Mihail Hristov, Norbert Pallua, Christian Weber, Jürgen Bernhagen et al.
    Journal of Cellular and Molecular Medicine
  17. IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells.
    Authors: Weiss N, Deboux C, Chaverot N, Miller F, Baron-Van Evercooren A, Couraud P, Cazaubon S
    J Neuroimmunol, 2010-04-18;223(1):131-4.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  18. CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis.
    Authors: Ouwehand K, Santegoets SJ, Bruynzeel DP, Scheper RJ, de Gruijl TD, Gibbs S
    Eur. J. Immunol., 2008-11-01;38(11):3050-9.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  19. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
    Authors: Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW
    Cancer Res., 2007-05-01;67(9):4244-53.
    Species: Human
    Sample Types: Cell Lysates, Whole Cells, Whole Tissue
    Applications: ICC, IHC-P, Western Blot
  20. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.
    Authors: Singh S, Singh UP, Grizzle WE, Lillard JW
    Lab. Invest., 2004-12-01;84(12):1666-76.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  21. Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus.
    Authors: Wald O, Pappo O, Safadi R, Dagan-Berger M, Beider K, Wald H, Franitza S, Weiss I, Avniel S, Boaz P, Hanna J, Zamir G, Eid A, Mandelboim O, Spengler U, Galun E, Peled A
    Eur. J. Immunol., 2004-04-01;34(4):1164-74.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  22. Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry.
    Authors: Hatse S, Princen K, Vermeire K, Gerlach LO, Rosenkilde MM, Schwartz TW, Bridger G, De Clercq E, Schols D
    FEBS Lett., 2003-07-10;546(2):300-6.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  23. CXCR4 function requires membrane cholesterol: implications for HIV infection.
    Authors: Nguyen DH, Taub D
    J. Immunol., 2002-04-15;168(8):4121-6.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry, Neutralization

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human CXCR4 Antibody

There are currently no reviews for this product. Be the first to review Human CXCR4 Antibody and earn rewards!

Have you used Human CXCR4 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review